NEXT Biometrics Group ASA — Share Issue/Capital Change 2014

Jun 11, 2014

NEXT Biometrics Group - Status of bookbuilding

NEXT Biometrics Group - Status of bookbuilding

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR

INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA,

AUSTRALIA, HONG KONG OR JAPAN OR ANY OTHER

JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE

WOULD BE UNLAWFUL

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS

STOCK EXCHANGE NOTICE

NEXT Biometrics Group - Status of bookbuilding

Oslo, 11 June 2014: NEXT Biometrics Group ASA ("NEXT

Biometrics" or the "Company") updates the market on

the status of the bookbuilding for the Company's

initial public offering (the "Offering") of its

shares following its recent application for admission

for trading and listing on Oslo Axess.

Reference is made to the stock exchange release from

the Company dated 6 June 2014.

The joint bookrunners in the initial public offering

of Next Biometrics have now registered orders within

the indicative price range which more than cover the

base deal of 1,600,000 New Shares and up to 130,000

Sale Shares as well as the 15% over-allotment option

offered by the Company.

The Bookbuilding Period for the Institutional

Offering runs until 16:30 CET on 19 June 2014 and the

Application Period for the Retail Offering runs until

12:00 CET on 19 June 2014, both subject to shortening

or extension.

Arctic Securities ASA and Carnegie AS are acting as

joint-lead managers and joint bookrunners in

connection with the Offering.

About NEXT Biometrics:

Enabled by its patented Active Thermal Principle,

NEXT Biometrics offers high quality area fingerprint

sensor at low prices. A wide range of products format

including Smartphones, tablets, PC's, doors, time

registration systems, payment terminals, flashdrives,

USB-tokens, keyfobs and many more are targeted. NEXT

Biometrics is headquartered in Oslo, Norway, with

sales, support and development subsidiaries in

Seattle, Taipei and Shanghai.

For more information about the company, please visit

www.nextbiometrics.com.

IMPORTANT NOTICE:

These materials are not an offer for sale of

securities.

Copies of this announcement are not being made and

may not be distributed or sent into the United

States, Canada, Australia, Hong Kong, Japan or any

other jurisdiction in which such distribution would

be unlawful or would require registration or other

measures.

The securities have not been registered under the

U.S. Securities Act of 1933, as amended

(the "Securities Act"), and may not be offered or

sold in the United States absent registration or an

exemption from the registration requirements of the

Securities Act. The Company does not intend to

register any part of the offering in the United

States or to conduct a public offering of securities

in the United States.

Any offering of securities will be made by means of a

prospectus that may be obtained from the issuer or

selling security holder and that will contain

detailed information about the Company and

management, as well as financial statements. This

document is an advertisement and not a prospectus for

the purposes of Directive 2003/71/EC (together with

any applicable implementing measures in any Member

State, the "Prospectus Directive"). Investors should

not subscribe for any securities referred to in this

document except on the basis of information contained

in the prospectus.

In any EEA Member State other than Norway that has

implemented the Prospectus Directive, this

communication is only addressed to and is only

directed at qualified investors in that Member State

within the meaning of the Prospectus Directive, i.e.,

only to investors who can receive the offer without

an approved prospectus in such EEA Member State.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR

INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR

DISSEMINATION IN THE UNITED STATES, AUSTRALIA, CANADA

OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE

DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

This communication is only being distributed to and

is only directed at (i) persons who are outside the

United Kingdom or (ii) to investment professionals

falling within Article 19(5) of the Financial

Services and Markets Act 2000 (Financial Promotion)

Order 2005 (the "Order") or (iii) above together

being referred to as "relevant persons"). The

securities are only available to, and any invitation,

offer or agreement to subscribe, purchase or

otherwise acquire such securities will be engaged in

only with, relevant persons. Any person who is not a

relevant person should not act or rely on this

document or any of its contents.

Matters discussed in this release may constitute

forward-looking statements. Forward-looking

statements are statements that are not historical

facts and may be identified by words such

as "believe," "expect," "anticipate," "intends," "esti

mate," "will," "may," "continue," "should" and

similar expressions. The forward-looking statements

in this release are based upon various assumptions,

many of which are based, in turn, upon further

assumptions. Although the Company believes that these

assumptions were reasonable when made, these

assumptions are inherently subject to significant

known and unknown risks, uncertainties, contingencies

and other important factors which are difficult or

impossible to predict and are beyond its control.

Such risks, uncertainties, contingencies and other

important factors could cause actual events to differ

materially from the expectations expressed or implied

in this release by such forward-looking statements.

The information, opinions and forward-looking

statements contained in this release speak only as at

its date, and are subject to change without notice.

This information is subject of the disclosure

requirements pursuant to section 5-12 of the

Norwegian Securities Trading Act.